| 标题 |
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Int J Cancer 作者:Zhang L, Wu ZY, Li J, Lin Y, Liu Z, Cao Y, Zhang G, Gao HF, Yang M, Yang CQ, Zhu T, Cheng MY, Ji F, Li J, Wang K 出版日期:2021-10-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)